• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Healthmortality rate

The COVID recession may kill more Americans than COVID-19 does

Geoff Colvin
By
Geoff Colvin
Geoff Colvin
Senior Editor-at-Large
Down Arrow Button Icon
Geoff Colvin
By
Geoff Colvin
Geoff Colvin
Senior Editor-at-Large
Down Arrow Button Icon
January 6, 2021, 9:55 AM ET

The economic effects of COVID-19 could prove deadlier than the disease itself. 

So says just-released research, which concludes that the total lives lost to the virus in the U.S. may “far exceed those immediately related to the acute COVID-19 critical illness…The recession caused by the pandemic can jeopardize population health for the next two decades.”

The new working paper, by authors at Duke University, Harvard Medical School, and the Johns Hopkins University business school, focuses on the almost instantaneous unemployment of millions of workers in March and April. The unemployment rate jumped from nearly the lowest in 50 years to the highest since the current measurement system began in 1948. While it has come down, it’s still at its highest rate since the recovery from the 2008–09 financial crisis.  

The authors wondered how unemployment affects mortality and life expectancy years later. Little research on that question existed, so they conducted their own analysis using 67 years of data about unemployment, life expectancy, and death rates from the Bureau of Labor Statistics and the Centers for Disease Control and Prevention. They were able to separate the effects of the unprecedented 2020 unemployment spike from other factors that affect mortality and life expectancy.

Their main finding: Over the next 20 years, 1.37 million more people will die than would have died without the unemployment shock the pandemic caused, a number the researchers call “staggering.” They find also that “excess deaths will disproportionately affect African-Americans.” The implied increases in deaths per 100,000 individuals over the next 20 years are 32.6 for African-Americans versus 24.6 for white Americans. In all, about 3.2% more people would die in the U.S. over that span than would have died without the spike in joblessness.

These new findings further complicate the excruciating quandary facing policymakers. Lockdowns and other restrictions impose economic suffering but save lives. If it turns out that the economic suffering, while saving lives in the near term, also costs lives in later years, then what is the right policy response? The researchers emphasize that “we do not want to suggest that policymakers should refrain from ordering lockdowns as necessary lifesaving measures”; rather, policy should also provide “enhanced health and economic support for the most vulnerable portions of the population.”

In the U.S., that support has been provided, at least partially, through stimulus checks, extra unemployment insurance, and other measures enacted last spring and in December. So could the new paper’s predictions of excess deaths be overblown? Maybe, but other factors suggest they could be underestimated. 

On the upside, we’ve never experienced a recession that reversed as quickly as this one, which struck suddenly but then bounced back sharply within months. The economy might now recover much faster than it did after past downturns, easing the damage to life expectancy. In addition, the researchers note, “this is the first recession with the Affordable Care Act in place, a critical resource to mitigate the effects of unemployment on citizens’ well-being.”

But the potential downside in this singular crisis is also formidable. The researchers catalog the dangers: “Based on emerging data, it is likely that the limited access to health care during the lockdown, temporary discontinuation of preventive care interventions, massive loss of employer-provided health insurance coverage, and the lingering concern of the population about seeking medical care out of fear of contracting COVID-19 will impact mortality rate and life expectancy even more severely” than predicted.

The new findings pose one more challenge for policymakers and everyone else. We mostly know who is dying of COVID-19 itself, and those depressing numbers, each accompanied by a name, drive a sense of urgency as we fight back. In coming decades, we will never know exactly whose lives have been shortened by the economic distress the pandemic caused. But that suffering will be just as real and shouldn’t be forgotten or ignored.

About the Author
Geoff Colvin
By Geoff ColvinSenior Editor-at-Large
LinkedIn iconTwitter icon

Geoff Colvin is a senior editor-at-large at Fortune, covering leadership, globalization, wealth creation, the infotech revolution, and related issues.

See full bioRight Arrow Button Icon

Latest in Health

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.


Most Popular

placeholder alt text
North America
'I meant what I said in Davos': Carney says he really is planning a Canada split with the U.S. along with 12 new trade deals
By Rob Gillies and The Associated PressJanuary 28, 2026
3 days ago
placeholder alt text
Politics
The American taxpayer spent nearly half a billion dollars deploying federal troops to U.S. cities in 2025, CBO finds
By Nick LichtenbergJanuary 28, 2026
2 days ago
placeholder alt text
Economy
Right before Trump named Warsh to lead the Fed, Powell seemed to respond to some of his biggest complaints about the central bank
By Jason MaJanuary 30, 2026
14 hours ago
placeholder alt text
C-Suite
Jeff Bezos capped his Amazon salary at $80,000: ‘How could I possibly need more incentive?’
By Sydney LakeJanuary 28, 2026
3 days ago
placeholder alt text
C-Suite
Fortune 500 CEOs are no longer giving employees an A for effort. Now they want proof of impact
By Claire ZillmanJanuary 28, 2026
3 days ago
placeholder alt text
AI
Top engineers at Anthropic, OpenAI say AI now writes 100% of their code—with big implications for the future of software development jobs
By Beatrice NolanJanuary 29, 2026
1 day ago

Latest in Health

Healthsleep
9 Best Mattresses for Couples in 2026: Tested and Reviewed
By Christina SnyderJanuary 30, 2026
10 hours ago
Healthoutdoor and sporting goods
5 Best Sauna Blankets of 2026: Tested by Recovery Experts
By Christina SnyderJanuary 30, 2026
14 hours ago
A person laying on a bed in a store.
Healthmattresses
How to Choose a Mattress: The Ultimate Guide
By Jessica RendallJanuary 30, 2026
17 hours ago
HealthScience
As billionaires chase immortality, this startup cofounded by a Harvard genetics professor gets FDA approval for the first partial de-aging human trial
By Marco Quiroz-GutierrezJanuary 30, 2026
22 hours ago
C-SuiteFortune 500: Titans and Disruptors of Industry
Pfizer CEO says he used ‘emotional blackmail’ to get employees to achieve impossible goals during COVID-19
By Eva RoytburgJanuary 29, 2026
1 day ago
man
HealthHealth
Life is actually getting better—and longer—for Americans, despite everything you read in the news
By Mike Stobbe and The Associated PressJanuary 29, 2026
1 day ago